Enzo Biochem Inc. (ENZ): Net earnings per share growth forecast for next year
High barriers to entry are ensured by strict FDA control and DNA labeling patents for Enzo Biochem, Inc. (ENZ). Currently, the business relies on the production of reagents for molecular analysis. The projected earnings per share growth target helps identify the asset's undervaluation phase, while 0.00 reflects the latest value of the metric. Vertical integration and proprietary developments in genomics make the company an independent innovation center.
Enzo Biochem - analytical breakdowns and key metrics (ENZ)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and market ratios statistics:
ENZ - Net Income|Projected Future Earnings Enzo Biochem, Inc.|ENZ - Company Value to Net Income|Forward P/E Multiple Enzo Biochem Inc.|ENZ - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Enzo Biochem|ENZ - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Enzo Biochem|ENZ - Earnings per share for the trailing year|Quarterly EPS earnings growth enzo.com|ENZ - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Enzo Biochem, Inc.
Summary company analysis:Enzo Biochem, Inc., ENZ
The scientific authority of Enzo Biochem, Inc. (ENZ) in molecular diagnostics allows experts to extrapolate the demand for innovative tests into future financial results. By analyzing expectations for the company's EPS growth next year, investors assess profit sensitivity to macroeconomic shifts, utilizing this chart to identify trend reversal points and verify the resilience of the business model in a changing environment.
Competitor analysis
A (Agilent Tech) - Earnings growth forecast for next year|Expected net earnings per share growth next year Quest Corp DGX|Net earnings per share growth forecast for next year Illumina, Inc. (ILMN)|exactsciences.com - Projected earnings per share growth rate for next year|Revvity - Expected earnings per share growth for next year|BIO (Bio-Rad Laboratories, Inc.) - Net earnings per share change forecast for next year|NNNN - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Nordion|QDEL (QuidelOrtho) - Expected earnings per share growth for next year|opko.com - Expected earnings per share trend next year|CDNA (CareDx, Inc.) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year MRVI|Earnings growth forecast for next year FLGT|Consensus forecast of earnings per share growth for next year Standard BioTools Corp|Net earnings per share growth forecast for next year Cytek Biosciences, Inc. CTKB|orasure.com (OSUR) - Expected net earnings per share growth next year|Exagen Diagnostics - Earnings growth forecast for next year|MDxHealth S.A. (MDXH) - Expected earnings per share growth for next year|LUCD: Earnings growth forecast for next year|Prenetics - Expected earnings per share trend next year|IMDX (Insight Molecular Diagnostics, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Trinity Biotech Corp TRIB|Net earnings per share growth forecast for next year ProPhase Labs (PRPH)|Expected earnings per share growth for next year Ainos Inc AIMD|Co-Diagnostics Corp - Expected earnings per share growth for next year|Expected earnings per share trend next year HSCS|Biomerica, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Cardio Diagnostics CDIO|Onconetix (ONCO) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year VRAX|BJDX (Bluejay) - Earnings growth forecast for next year|Expected earnings per share growth for next year Aspira Women's Health Inc (AWH)|Expected earnings per share growth for next year AXDX (Accelerate Diagnostics)|Consensus forecast of earnings per share growth for next year CENTOGENE, N.V.|Earnings growth forecast for next year FRES (Fresh2 Group)|Genetic Technologies Ltd (GENE) - Expected net earnings per share growth next year|ME - Net earnings per share growth forecast for next year|PMD (Psychemedics Inc) - Projected earnings per share growth rate for next year
